Renaissance Technologies LLC Raises Holdings in U.S. Physical Therapy, Inc. $USPH

Renaissance Technologies LLC raised its holdings in U.S. Physical Therapy, Inc. (NYSE:USPH) by 23.4% during the first quarter, Holdings Channel.com reports. The firm owned 76,956 shares of the company’s stock after purchasing an additional 14,582 shares during the period. Renaissance Technologies LLC’s holdings in U.S. Physical Therapy were worth $5,769,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of USPH. Royal Bank of Canada raised its holdings in U.S. Physical Therapy by 3.4% in the 1st quarter. Royal Bank of Canada now owns 79,238 shares of the company’s stock valued at $5,733,000 after buying an additional 2,594 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in shares of U.S. Physical Therapy by 4.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 8,897 shares of the company’s stock valued at $644,000 after acquiring an additional 391 shares during the last quarter. Jane Street Group LLC raised its stake in shares of U.S. Physical Therapy by 249.3% in the 1st quarter. Jane Street Group LLC now owns 49,309 shares of the company’s stock valued at $3,568,000 after acquiring an additional 35,191 shares during the period. Hsbc Holdings PLC acquired a new position in shares of U.S. Physical Therapy in the 2nd quarter worth approximately $410,000. Finally, First Trust Advisors LP lifted its holdings in shares of U.S. Physical Therapy by 3.7% in the 2nd quarter. First Trust Advisors LP now owns 10,725 shares of the company’s stock worth $839,000 after acquiring an additional 385 shares during the last quarter.

Insiders Place Their Bets

In other news, Director Peter Francis Minan bought 492 shares of U.S. Physical Therapy stock in a transaction that occurred on Monday, June 8th. The shares were purchased at an average price of $63.14 per share, with a total value of $31,064.88. Following the completion of the acquisition, the director directly owned 2,923 shares in the company, valued at $184,558.22. The trade was a 20.24% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. 2.40% of the stock is currently owned by company insiders.

U.S. Physical Therapy Trading Up 1.9%

NYSE:USPH opened at $77.33 on Thursday. The firm has a market cap of $1.18 billion, a PE ratio of 154.67, a price-to-earnings-growth ratio of 2.10 and a beta of 1.13. The stock has a fifty day moving average price of $69.62 and a 200 day moving average price of $74.26. U.S. Physical Therapy, Inc. has a 12-month low of $58.19 and a 12-month high of $93.50. The company has a current ratio of 1.19, a quick ratio of 1.19 and a debt-to-equity ratio of 0.41.

U.S. Physical Therapy (NYSE:USPH) last issued its quarterly earnings results on Wednesday, August 5th. The company reported $0.75 earnings per share for the quarter, missing the consensus estimate of $0.81 by ($0.06). U.S. Physical Therapy had a return on equity of 8.81% and a net margin of 4.36%.The company had revenue of $214.06 million for the quarter, compared to analysts’ expectations of $211.36 million. During the same quarter last year, the company earned $0.81 EPS. U.S. Physical Therapy’s revenue for the quarter was up 8.5% compared to the same quarter last year. Sell-side analysts anticipate that U.S. Physical Therapy, Inc. will post 2.99 earnings per share for the current fiscal year.

U.S. Physical Therapy Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, September 11th. Investors of record on Friday, August 21st will be paid a dividend of $0.46 per share. This represents a $1.84 dividend on an annualized basis and a dividend yield of 2.4%. The ex-dividend date is Friday, August 21st. U.S. Physical Therapy’s dividend payout ratio is presently 368.00%.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on USPH. Zacks Research raised U.S. Physical Therapy from a “strong sell” rating to a “hold” rating in a research report on Wednesday, May 27th. Citigroup reiterated a “market outperform” rating on shares of U.S. Physical Therapy in a report on Friday, July 24th. Citizens Jmp reissued a “market outperform” rating and set a $98.00 target price on shares of U.S. Physical Therapy in a research note on Wednesday, June 24th. Barrington Research dropped their target price on U.S. Physical Therapy from $103.00 to $90.00 and set an “outperform” rating for the company in a research report on Wednesday, May 13th. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of U.S. Physical Therapy in a research report on Friday, May 29th. One equities research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, U.S. Physical Therapy currently has an average rating of “Moderate Buy” and a consensus price target of $97.50.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S.